| ASSET | YEAR | % RETURN |
|---|---|---|
BioLife Solutions (BLFS) | 1991 | 765.98% |
Oppenheimer (OPY) | 1991 | 478.99% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Mesa Laboratories (MLAB) | 1991 | 361.56% |
National HealthCare (NHC) | 1991 | 335.89% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Celldex Therapeutics (CLDX) | 1991 | 282.61% |
Hovnanian Enterprises (HOV) | 1991 | 281.82% |
Bel Fuse A (BELFA) | 1991 | 268.42% |
ODP (ODP) | 1991 | 228.46% |
CECO Environmental (CECO) | 1991 | 222.21% |
Axogen (AXGN) | 1991 | 217.86% |
Universal (UVV) | 1991 | 189.37% |
CONMED (CNMD) | 1991 | 183.34% |
Digi International (DGII) | 1991 | 168.29% |
Tat Techno (TATT) | 1991 | 162.67% |
Cracker Barrel Old Country Store (CBRL) | 1991 | 155.86% |
Lindsay (LNN) | 1991 | 147.43% |
Great Southern Bancorp (GSBC) | 1991 | 144.88% |
Benchmark Electronics (BHE) | 1991 | 134.14% |
Matrix Service (MTRX) | 1991 | 131.82% |
Oxford Industries (OXM) | 1991 | 130.64% |
Neonode (NEON) | 1991 | 113.95% |
Franklin BSP Realty Trust (FBRT) | 1991 | 111.71% |
Astronics (ATRO) | 1991 | 111.08% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
